Original, source-linked analysis with study design, model boundaries and limitations kept visible. Research findings are not device-wide promises.
For professional education and institutional evaluation. Published research is not authorization for use in Mexico or another country. Confirm the exact device, local registration, current instructions and institutional permissions before clinical use.
Source-based editorial analysis by OMNIBOT MX. No independent medical reviewer is asserted. Read the original publication and assess applicability with your institution.
The comparison is remote versus local operation on the study platform, not superiority over another robot. It supports short-term reliability within the specified margin and protocol. Credible intervals, withdrawal and short follow-up remain important when interpreting applicability.
Ye Wang, Dan Xia · BMJ; 392:e083588
72 randomized patients; 36 per arm, five centers.
Small cohort, 12.5% withdrawal, expert-selected margin and 4–6-week follow-up. No long-term or economic conclusions.
The series suggests reconstructive feasibility in a selected setting. It does not demonstrate comparative effectiveness or durable patency. Different reconstructive operations should not be treated as one uniform indication, and results require longer follow-up.
Bing Wang, Wenzhi Gao · Translational Andrology and Urology; 14(6):1723–1733
20 patients; one surgeon; prospective single-arm study.
Small uncontrolled expert-surgeon series with mixed reconstructive procedures and short follow-up. Inconsistent ergonomics scores are omitted.